ACTRN12623000133639
Not yet recruiting
Phase 4
Continuous infusion of remimazolam for intraoperative sedation as a safe and effective option: a prospective clinical study.
Antonia Kustura, MD0 sites50 target enrollmentFebruary 8, 2023
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Procedural or intraoperative sedation.
- Sponsor
- Antonia Kustura, MD
- Enrollment
- 50
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult patients between 18 and 80 years of age, ASA class I, II and III, scheduled for elective procedural sedation or sedation with regional anaesthesia.
Exclusion Criteria
- •Exclusion criteria are age under 18 or over 80, allergy to any of the drugs used, body mass index (BMI) under 18 or over 30, patients with psychiatric diagnoses, and patient refusal.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Anesthetic induction using remimazolam in patients undergoing cardiac surgeryDiseases of the circulatory systemKCT0006931Asan Medical Center60
Completed
Not Applicable
Remimazolam during induction of anesthesia in patients with severe aortic stenosisSevere aortic stenosisJPRN-UMIN000042318agoya City University Graduate School of Medical Sciences, Department of Anesthesiology and Intensive Care Medicine20
Recruiting
Not Applicable
Efficacy and safety of general anestheticsScheduled non-cardiac surgeries under general anesthesiaJPRN-jRCTs061230049Miyoshi Hirotsugu69
Completed
Not Applicable
Adequate infusion rate of remimazolam for induction of general anesthesia in adult patientsKCT0006805Samsung Medical Center44
Not yet recruiting
Not Applicable
Adequate infusion rate of remimazolam for induction of general anesthesia in elderly patients aged 65 or olderNot ApplicableKCT0007902Samsung Medical Center50